The Kanakee project builds on the biopharma company’s efforts to increase its U.S. footprint, where it has already spent more than $3 billion, and will focus on producing plasma-derived therapies.
Categories:
Related Post
Construction surges despite cost, power concerns
Municipal pushback and access to energy pose risks to future data center development, said Ermengarde…
Skanska starts $312M New Jersey women’s prison
The design of a 400-bed, 33-acre campus in Chesterfield Township will target a safe, secure…
Michigan creates mass timber program in construction adoption push
The state will offer money, guidance and technical assistance as demand increases for the alternative…